Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Inhibition of p300/CBP Overcomes BTK Inhibitor Resistance in MCL By Counteracting IL-6/JAK/STAT3 Signaling

Yusuke Tashiro, Kotaro Shirakawa, Hiroshi Arima, Ryosuke Nomura, Yoshihito Horisawa, Stanford Emani, Suguru Takeuchi, Jelagat Caroline, Yasuhiro Kazuma, Hiroyuki Matsui, Tadahiko Matsumoto, Kosuke Yusa, Akifumi Takaori-Kondo

Blood (2024) 144 (Supplement 1): 5843.

https://doi.org/10.1182/blood-2024-206382

Published: 2024

Journal Articles

Interactome Analysis of APOBEC3B in Multiple Myeloma

Yasuhiro Kazuma, MD, Kotaro Shirakawa, MD PhD, Anamaria Daniela Sarca, MD, Yoshihito Horisawa, MD, Hirofumi Fukuda, MD, Hiroyuki Matsui, MD, Hiroyuki Yamazaki, MD, Tadahiko Matsumoto, MD, Fumiko Tanabe, Ryo Morishita, PhD, Shinji Ito, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2019) 134 (Supplement_1): 1259.

https://doi.org/10.1182/blood-2019-126856

Published: 2019

Journal Articles

Selective HDAC3 Inhibition Induces Apoptosis in B Cell Lymphoma through Protein Acetylation

Hiroyuki Matsui, MD, Kotaro Shirakawa, MD PhD, Hsin-Yi Chang, PhD, Anamaria Daniela Sarca, MD, Yasuhiro Kazuma, MD, Hirofumi Fukuda, MD, Hiroyuki Yamazaki, MD, Tadahiko Matsumoto, MD, Yasushi Ishihama, PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2018) 132 (Supplement 1): 1583.

https://doi.org/10.1182/blood-2018-99-112853

Published: 2018

Journal Articles

Aberrantly Expressed APOBEC3B Induces Mutations in Multiple Myeloma

Hiroyuki Yamazaki, MD, Kotaro Shirakawa, MD PhD, Tadahiko Matsumoto, MD, Hiroyuki Matsui, MD, Wataru Maruyama, MD, Masayuki Kobayashi, MD PhD, Keisuke Shindo, MD PhD, Anamaria Daniela Sarca, MD, Masaki Ri, MD PhD, Shinsuke Iida, MD PhD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 4453.

https://doi.org/10.1182/blood.V128.22.4453.4453

Published: 2016

Journal Articles

PKA-Mediated Phosphorylation of APOBEC3B Suppresses Its DNA Mutagenic Potential in Myeloma Cells

Tadahiko Matsumoto, MD, Kotaro Shirakawa, MD PhD, Hiroyuki Matsui, MD, Hiroyuki Yamazaki, MD, Yasuhiro Kazuma, MD, Anamaria Daniela Sarca, MD, Hirofumi Fukuda, MD, Wataru Maruyama, MD, Akifumi Takaori-Kondo, MD PhD

Blood (2016) 128 (22): 4427.

https://doi.org/10.1182/blood.V128.22.4427.4427

Published: 2016

Journal Articles

Favorable Outcome of Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia

Fumie Iwai, Hitomi Kaneko, MD, PhD, Goichi Tatsumi, Tadahiko Matsumoto, Shinya Inada, Yuki Sueki, Nao Toyooka, Sumie Fujii, Chisiho Nakamura, Mitsumasa Watanabe, MD, PhD, Hirokazu Hirata, MD, PhD, Yasuo Miura, MD, PhD, Mitsuru Tsudo, MD, PhD

Blood (2011) 118 (21): 4480.

https://doi.org/10.1182/blood.V118.21.4480.4480

Published: 2011

NARROW

Inhibition of p300/CBP Overcomes BTK Inhibitor Resistance in MCL By Counteracting IL-6/JAK/STAT3 Signaling

Interactome Analysis of APOBEC3B in Multiple Myeloma

Selective HDAC3 Inhibition Induces Apoptosis in B Cell Lymphoma through Protein Acetylation

Aberrantly Expressed APOBEC3B Induces Mutations in Multiple Myeloma

PKA-Mediated Phosphorylation of APOBEC3B Suppresses Its DNA Mutagenic Potential in Myeloma Cells

Favorable Outcome of Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia

Email alerts

ASH Publications

American Society of Hematology

Inhibition of p300/CBP Overcomes BTK Inhibitor Resistance in MCL By Counteracting IL-6/JAK/STAT3 Signaling

Interactome Analysis of APOBEC3B in Multiple Myeloma

Selective HDAC3 Inhibition Induces Apoptosis in B Cell Lymphoma through Protein Acetylation

Aberrantly Expressed APOBEC3B Induces Mutations in Multiple Myeloma

PKA-Mediated Phosphorylation of APOBEC3B Suppresses Its DNA Mutagenic Potential in Myeloma Cells

Favorable Outcome of Reduced-Intensity Stem Cell Transplantation for Adult T-Cell Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only